[1] RAJESHKUMAR ANBAZHAGAN. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance[J]. Biotechnology and Bioengineering, 2020, 118 3: 1213-1223. DOI:
10.1002/bit.27645[2] GABRIELLA CAMINATI Donald A T Nicholas J Turro. Photophysical investigation of starburst dendrimers and their interactions with anionic and cationic surfactants[J]. Journal of the American Chemical Society, 1990, 112 23: 8515-8522. DOI:
10.1021/ja00179a041[3] DZMITRY SHCHARBIN. The breakdown of bilayer lipid membranes by dendrimers.[J]. Cellular & Molecular Biology Letters, 2006, 11 2: 242-248. DOI:
10.2478/s11658-006-0018-2[4] GORDON J. KIRKPATRICK . Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin[J]. Journal of Inorganic Biochemistry, 2011, 105 9: Pages 1115-1122. DOI:
10.1016/j.jinorgbio.2011.05.017[5] NATALIA ODDONE. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.[J]. Journal of Nanobiotechnology, 2016, 14 1: 45. DOI:
10.1186/s12951-016-0197-6